HTG2014-Section-Header-publications

Categories

Filter by Topics

AACR2023 ALK aplastic anemia AA Autoimmune Disorder B-cell lymphoma Biology of neoplasia Biomarkers Bladder Cancer bone Brain Breast Cancer CD3 Cells Cerebrospinal Fluid clinical trial cold tumor Colorectal cancer Comparison study CXCL12 Cytokines Developmental Immunotherapy Developmental Therapeutics Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug sensitivity EHE cancer Encephalophy EPCORE NHL-1 ERBB3 FFPE Gene Expression Profiling Genetic Polymorphism Heart Histone Deacetylase Inhibitors hot tumor HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq Lung Fusion Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq System HTP Immune Checkpoint Inhibitors Immune Response Immune-related Colitis Immuno-Oncology IMMUNOSARC Immunotherapy IOA- 244 IRP Kidney Liposarcoma liver Liver Lung lungs Lymphoma lymphoma Melanoma melanoma Microenvironment miRNA miRNA WTA Molecular Characterization Nash and Fibrosis Natural Killer Cells Nestin+ Neurologic non-Hodgkin Lymphoma Non-Hodgkin lymphoma NHL OBP Oesophageal Adenocarcinoma Oral cancer oral squamous cell carcinoma OSCC PanB Pancreas pancreatic ductal adenocarcinoma PDAC Parkinson's Disease Pathway Analysis PDX model PI3K inhibitors PIP Plasma Platform Comparison Programmed cell death protein 1 Prostate qNPA qPCR Radioimmunotherapy Rheumatoid Arthritis Sarcoma Serum Signatures soft tissue sarcoma Sub-typing Survival plots T cells Thymic Carcinoma Tislelizumab TME Transplantation Treatment Outcome Treatment Targets Tumor Biology Tumor Immunobiology Tumor infiltrating lymphocytes Zanubrutinlb

2013

Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC.

Rounseville M., et al. Development of an automated RNA-based nuclease protection assay for the detection of expressed EML-ALK fusions, EGFR and KRAS mutations in NSCLC. J Clin Oncol. 2013;31(Suppl); abstr e22185.

View External Link

Targeted gene expression sequencing from FFPE: NPSeq™.

Thompson D., et al. Targeted gene expression sequencing from FFPE: NPSeq™. Cancer Res. 2013;73(8 Suppl):abstr 4146.

View External Link

Array-based Quantitative Nuclease Protection Assay Can Reproducibly Identify Prognostic mRNA Biomarkers in Archival Mantle Cell Lymphoma Specimens

Yang D., et al. Array-based Quantitative Nuclease Protection Assay Can Reproducibly Identify Prognostic mRNA Biomarkers in Archival Mantle Cell Lymphoma Specimens. Mod Pathol. 2013 Feb;26(S2):368A.

Download pdf 1.0MB

Investigation of a Redox-Sensitive Predictive Model of Mouse Embryonic Stem Cell Differentiation via Quantitative Nuclease Protection Assays and Gluthione Redox Status

Chandler K., et al. Investigation of a Redox-Sensitive Predictive Model of Mouse Embryonic Stem Cell Differentiation via Quantitative Nuclease Protection Assays and Gluthione Redox Status. Poster session presented at: 52nd Annual Society of Toxicology Meeting; 2013 Mar 10-14, San Antonio, TX.

View External Link

Automated Measurement of Gene Expression from FFPE: qNPA vs. qPCR

Rounseville M., et al. Automated Measurement of Gene Expression from FFPE: qNPA vs. qPCR. Poster session presented at: Molecular Med Tri-Con; 2013 Feb 11-15; San Francisco, CA

Download pdf 830KB

2011

Quantitative Nuclease Protection Assay (qNPA) for Gene Expression Analysis on Brest Cancer Core Biopsies.

Evangelist M., et al. Quantitative Nuclease Protection Assay (qNPA) for Gene Expression Analysis on Brest Cancer Core Biopsies. J Clin Oncol. 2011 Sep 20;29(Suppl 27);abstr 49.

View External Link

Identification of ALK gene alterations in urothelial carcinoma (UC).

Bellmunt, J. Identification of ALK gene alterations in urothelial carcinoma (UC). J Clin Oncol. 2011 Sep 20;29(Suppl 27);abstr 4568. 

View External Link

2010

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay.

Yang D., et al. Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay. Blood. 2010 Nov 19;116: abstr 2007.

View External Link

2009

A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma.

Wilkinson S., et al. A Comparison of Gene Expression Pattern in Major Histocompatibility Class II-Low Diffuse Large B-Cell Lymphoma with Plasmablastic Lymphoma. Blood. 2009;114:abstr 1941.

View External Link

Precise Multiplexed Measurement of Gene Expression: Quantitative Nuclease Protection Assay (qNPA™).

Coker P., et al. Precise Multiplexed Measurement of Gene Expression: Quantitative Nuclease Protection Assay (qNPA™). Proceedings of the 35th Annual Meeting of the Plant Growth Regulation Society of America.

View External Link

Page last updated May 22, 2023